Drug-drug interactions of direct oral anticoagulants (DOACs): from pharmacological to clinical practice

N Ferri, E Colombo, M Tenconi, L Baldessin, A Corsini - Pharmaceutics, 2022 - mdpi.com
The direct oral anticoagulants (DOACs), dabigatran, rivaroxaban, apixaban, and edoxaban,
are becoming the most commonly prescribed drugs for preventing ischemic stroke in …

Antithrombotic strategy in cancer patients comorbid with acute coronary syndrome and atrial fibrillation

T Wang, X Liu, Y Zhu, Y Zhang, Z Zhang… - Frontiers in …, 2023 - frontiersin.org
It has been shown that patients with cancer have a longer expected life duration, benefiting
from advanced medical therapy. Meanwhile, the risk of suffering from cardiovascular …

[HTML][HTML] Evaluating efficacy and safety of oral anticoagulation in adult patients with atrial fibrillation and cancer: a systemic review and meta-analysis

LA Ciuffini, A Delluc, TF Wang, C Lodigiani, M Carrier - Thrombosis Update, 2023 - Elsevier
Background Atrial fibrillation (AF) is common among patients with cancer. Patients with
cancer and AF require anticoagulant therapy [direct oral anticoagulants (DOAC) or vitamin K …

Update on drug interactions with non-vitamin-K-antagonist oral anticoagulants for stroke prevention in elderly patients

C Stoellberger, J Finsterer - Expert Review of Clinical …, 2021 - Taylor & Francis
Introduction: We update the knowledge, since the last review in 2017, about drug–drug
interactions (DDI) of non-vitamin-K-antagonist oral anticoagulants (NOAC) in patients≥ 75 …

Hemorrhage risk among patients with breast cancer receiving concurrent direct oral anticoagulants with tamoxifen vs aromatase inhibitors

TF Wang, AE Clarke, AA Awan… - JAMA Network …, 2022 - jamanetwork.com
Importance Tamoxifen is commonly used as adjuvant therapy in breast cancer and is
proposed to interfere with cytochrome P450 enzyme and P-glycoprotein pathways …

Drug-drug interactions with direct oral anticoagulants for the prevention of ischemic stroke and embolism in atrial fibrillation: a narrative review of adverse events

C Stöllberger, B Schneider… - Expert Review of Clinical …, 2023 - Taylor & Francis
Introduction In randomized trials, direct oral anticoagulants (DOAC) were non-inferior to the
vitamin-K-antagonist (VKA) warfarin in preventing stroke/embolism in patients with atrial …

Relationships, Current Issues, Safety and Efficacy of Oral Anticoagulation in Cancer Patients with Atrial Fibrillation

AG Franchina, M Rocchetti, E Sala, A Laricchia… - Journal of Clinical …, 2023 - mdpi.com
A relationship between malignancy and impaired hemostasis has been proven, and
balancing clotting and bleeding risks can be challenging. Half of cancer patients with atrial …

A systematic review of the efficacy and safety of direct oral anticoagulants in atrial fibrillation patients with diabetes using a risk index

D Acanfora, MM Ciccone, V Carlomagno… - Journal of Clinical …, 2021 - mdpi.com
Diabetes mellitus (DM) represents an independent risk factor for chronic AF and is
associated with unfavorable outcomes. We aimed to evaluate the efficacy and safety of …

The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation

AC Fender, D Dobrev - International …, 2021 - internationaljournalofcardiology.com
Atrial fibrillation (AF) is the most common arrhythmia, with a substantial rise in global
incidence and prevalence. Ischemic stroke is a frequent complication of AF, since AF …

Het 'three territory sign'als een merker van occulte maligniteit bij een beroerte

H Engels, M Lemmerling… - … VOOR NEUROLOGIE & …, 2022 - biblio.ugent.be
Een 89-jarige vrouw presenteerde zich op de Spoed-eisende Hulp met een transiënt verlies
van coördinatie van haar rechterarm. Op MRI met diffusiegewogen opnamen was het 'three …